After matching normal tissues from TCGA and GTEx databases, higher GBP1 expression levels were observed in tumors of diffuse large B-cell lymphoma (DLBC) (p < 0.05), acute myeloid (LAML) (p < 0.05), brain lower grade glioma (LGG) (p < 0.05), and testicular germ cell tumors (TGCT) (p < 0.05), while tumors of uterine carcinosarcoma (UCS) (p < 0.05) showed lower GBP1 expression compared to normal tissues (Figure 1B). This evidence concerns the gene GBP1 and diffuse large B-cell lymphoma.